Advertisement
Screener

IQVIA HOLDINGS INC. (IQV) Number of Reportable Segments

2.8 / 5 stars · 68/120 Roast Me

IQVIA HOLDINGS INC. Number of Reportable Segments

IQVIA HOLDINGS INC. (IQV) reported Number of Reportable Segments of 2 Segment for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.

Financial Statements › Notes

us-gaap:NumberOfReportableSegments · last filed 2026-05-05

  • IQVIA HOLDINGS INC. number of reportable segments for the quarter ending 2026-03-31 was 2.00 Segment, a 33.33% decline year-over-year.
  • IQVIA HOLDINGS INC. number of reportable segments for the quarter ending 2025-03-31 was 3.00 Segment, a 0.00% change year-over-year.
  • IQVIA HOLDINGS INC. number of reportable segments for the quarter ending 2024-03-31 was 3.00 Segment, a 0.00% change year-over-year.
  • IQVIA HOLDINGS INC. number of reportable segments for the quarter ending 2023-03-31 was 3.00 Segment, a 0.00% change year-over-year.
  • IQVIA HOLDINGS INC. number of reportable segments for fiscal 2025 was 3.00 Segment, a 0.00% change from fiscal 2024.
  • IQVIA HOLDINGS INC. number of reportable segments for fiscal 2024 was 3.00 Segment, a 0.00% change from fiscal 2023.
  • IQVIA HOLDINGS INC. number of reportable segments for fiscal 2023 was 3.00 Segment, a 0.00% change from fiscal 2022.
  • IQVIA HOLDINGS INC. number of reportable segments for fiscal 2022 was 3.00 Segment, a 0.00% change from fiscal 2021.
Period endNumber of Reportable Segments 3 monthNumber of Reportable Segments 6 monthNumber of Reportable Segments 9 monthNumber of Reportable Segments 12 month
2026-03-312.00 Segment
10-Q · filed 2026-05-05
2025-12-313.00 Segment
10-K · filed 2026-02-17
2025-09-303.00 Segment
10-Q · filed 2025-10-28
2025-06-303.00 Segment
10-Q · filed 2025-07-22
2025-03-313.00 Segment
10-Q · filed 2025-05-06
2024-12-313.00 Segment
10-K · filed 2025-02-13
2024-09-303.00 Segment
10-Q · filed 2024-10-31
2024-06-303.00 Segment
10-Q · filed 2024-07-22
2024-03-313.00 Segment
10-Q · filed 2024-05-02
2023-12-313.00 Segment
10-K · filed 2024-02-15
2023-09-303.00 Segment
10-Q · filed 2023-11-01
2023-06-303.00 Segment
10-Q · filed 2023-08-01
2023-03-313.00 Segment
10-Q · filed 2023-04-28
2022-12-313.00 Segment
10-K · filed 2023-02-15
2022-09-303.00 Segment
10-Q · filed 2022-10-27
2022-06-303.00 Segment
10-Q · filed 2022-07-22
2022-03-313.00 Segment
10-Q · filed 2022-04-28
2021-12-313.00 Segment
10-K · filed 2022-02-16
2021-09-303.00 Segment
10-Q · filed 2021-10-22
2021-06-303.00 Segment
10-Q · filed 2021-07-28
2021-03-313.00 Segment
10-Q · filed 2021-04-23
2020-12-313.00 Segment
10-K · filed 2021-02-12
2020-09-303.00 Segment
10-Q · filed 2020-10-22
2020-06-303.00 Segment
10-Q · filed 2020-07-23
2020-03-313.00 Segment
10-Q · filed 2020-04-30
2019-12-313.00 Segment
10-K · filed 2020-02-18
2019-09-303.00 Segment
10-Q · filed 2019-11-01
2019-06-303.00 Segment
10-Q · filed 2019-07-24
2019-03-313.00 Segment
10-Q · filed 2019-05-02
2018-12-313.00 Segment
10-K · filed 2019-02-19
2018-09-303.00 Segment
10-Q · filed 2018-10-25
2018-06-302.00 Segment
10-K · filed 2019-02-19
3.00 Segment
10-Q · filed 2018-07-27
2018-03-313.00 Segment
10-Q · filed 2018-05-04
2017-12-313.00 Segment
10-K · filed 2018-02-16
2017-09-303.00 Segment
10-Q · filed 2017-10-27
2017-06-303.00 Segment
10-Q · filed 2017-08-04
2017-03-313.00 Segment
10-Q · filed 2017-05-08
2016-12-313.00 Segment
10-K · filed 2017-02-16
2016-09-302.00 Segment
10-Q · filed 2016-11-03
2016-06-302.00 Segment
10-Q · filed 2016-07-27
2016-03-312.00 Segment
10-Q · filed 2016-05-03
2015-12-312.00 Segment
10-K · filed 2016-02-11
2015-09-302.00 Segment
10-Q · filed 2015-10-28
2015-06-302.00 Segment
10-Q · filed 2015-07-29
2015-03-312.00 Segment
10-Q · filed 2015-04-29
2014-12-312.00 Segment
10-K · filed 2015-02-12
2014-09-302.00 Segment
10-Q · filed 2014-10-30
2014-06-302.00 Segment
10-Q · filed 2014-07-31
2014-03-312.00 Segment
10-Q · filed 2014-05-01
2013-12-312.00 Segment
10-K · filed 2014-02-13
2013-09-302.00 Segment
10-Q · filed 2013-10-31
2013-06-302.00 Segment
10-Q · filed 2013-08-01
2013-03-312.00 Segment
10-Q · filed 2013-05-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
INCYTE CORP (INCY)United States$24.855B13.14
Medpace Holdings, Inc. (MEDP)United States$17.316B30.09
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)United States$14.060B-43.97
Absci Corp (ABSI)United States$1.775B-14.92
OmniAb, Inc. (OABI)United States$0.698B-8.05
NRC HEALTH (NRC)United States$0.450B42.50
MAXCYTE, INC. (MXCT)United States$0.124B-3.68
bioAffinity Technologies, Inc. (BIAF)United States$0.063B
OneMedNet Corp (ONMD)$0.042B
iSpecimen Inc. (ISPC)United States$0.003B